CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus
✍ Scribed by Cardillo, Marina ;Hagan, Robert ;Abadi, Jacobo ;Abadi, Maria A.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 80 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND.
Recent studies have reported an increased incidence of squamous intraepithelial lesions in women infected with the human immunodeficiency virus (HIV). However, to the authors' knowledge there are scarce data regarding the relation between the CD4 T-lymphocyte count (CD4ϩ), HIV viral load, and the development of cervical dysplasia as evidenced by cervicovaginal cytology. The objective of the current study was to examine the association between cervicovaginal smears (with and without squamous lesions) from HIV-infected women and their CD4ϩ counts and HIV viral load.
METHODS.
Two hundred ninety-six cervicovaginal smears from 108 HIV-infected women were reviewed and classified according to the Bethesda system. Abnormal cytologies (n ϭ 74) were followed by colposcopy and/or biopsy. CD4ϩ counts and HIV viral loads were available at the time of the cytologic evaluation. Statistical analysis was performed using the Student t test and the Mann-Whitney U test.
RESULTS.
The control group (n ϭ 222) had significantly higher CD4ϩ counts (378 vs. 246 cells/L; P Ͻ 0.001) compared with the group with cervical lesions. There was no apparent difference between the CD4ϩ counts from women with low grade lesions and those from women with high grade lesions. The HIV viral load was significantly higher in patients with cytologic abnormalities than in those with negative Papanicolaou smears (P ϭ 0.006).
CONCLUSIONS.
The degree of immunosuppression may contribute to the development of intraepithelial lesions in HIV-positive women, but once the lesion is established disease progression may not be affected by the CD4ϩ counts. Cancer
📜 SIMILAR VOLUMES
## Variability in CD4 1 T-lymphocyte measurements has been described for both normal and human immunodeficiency virus (HIV)-infected persons. Clinical protocols use CD4 1 cell counts as surrogate markers for disease progression or response. In this study, we determined the variability of CD4 1 T-l
We examined the genetic expression of 2 CXC chemokines (IL-8, IP-lo), 5 CC chemokines (MCP-I, MIP-la, MIP-IP, RANTES, 1309) and I C chemokine (SCM-I /lymphotactin/ ATAC) in various human T-cell lines. By Northern blot analysis, HTLV-I -positive T-cell lines were found to express a number of chemokin
## Abstract We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for __Mycobac